CVE-2020-14525
Summary
| CVE | CVE-2020-14525 |
|---|---|
| State | PUBLIC |
| Assigner | [email protected] |
| Source Priority | CVE Program / NVD first with legacy fallback |
| Published | 2020-09-18 18:15:00 UTC |
| Updated | 2020-09-25 18:51:00 UTC |
| Description | Philips Clinical Collaboration Platform, Versions 12.2.1 and prior. The software does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output used as a webpage that is served to other users. |
Risk And Classification
Problem Types: NVD-CWE-Other
NVD Known Affected Configurations (CPE 2.3)
| Type | Vendor | Product | Version | Update | Edition | Language |
|---|---|---|---|---|---|---|
| Application | Philips | Clinical Collaboration Platform | All | All | All | All |
References
| Reference | Source | Link | Tags |
|---|---|---|---|
| Philips Clinical Collaboration Platform | CISA | MISC | us-cert.cisa.gov | Third Party Advisory, US Government Resource |
| CVE Program record | CVE.ORG | www.cve.org | canonical |
| NVD vulnerability detail | NVD | nvd.nist.gov | canonical, analysis |
No vendor comments have been submitted for this CVE.
There are currently no legacy QID mappings associated with this CVE.